Budd-Chiari Syndrome is a rare condition affecting the veins that drain blood from the liver. The blockage can happen anywhere from the small veins in the liver to the large vein that connects to the heart. This blockage can cause swelling in the abdomen and liver problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Coumadin (Warfarin) for Budd-Chiari Syndrome?
Budd-Chiari syndrome is a rare condition in which the veins that carry blood out of the liver become blocked. The blockage can sit anywhere from the small hepatic veins inside the liver to the point where they empty into the inferior vena cava, the large vein that returns blood from the lower body to the heart. Most often the cause is a blood clot. In some people, the problem is a thin membrane or narrowing inside the vena cava itself. When blood cannot leave the liver, it backs up. The liver becomes congested and swollen, its cells are starved of oxygen and damaged, and pressure rises in the veins that feed the liver (portal hypertension). That backed-up pressure explains the condition's main effects: fluid collecting in the abdomen (ascites), an enlarged and often tender liver, leg swelling and, over time, scarring of the liver. Budd-Chiari syndrome can develop suddenly over days or weeks, or slowly over months to years. The slower, chronic form is more common and is sometimes mistaken for cirrhosis from another cause. About 15% of people have no symptoms when it is found, because new detour veins have grown around the blockage. Unlike most liver diseases, it tends to appear in younger adults, often between 20 and 45.
Budd-Chiari syndrome is usually a sign that the blood clots more easily than it should, and finding that reason is a central part of care. In Western countries, the most common underlying cause is a myeloproliferative neoplasm, a group of slow-growing bone marrow disorders (such as polycythemia vera) in which the marrow makes too many blood cells. These disorders are found in roughly a third to half of people with Budd-Chiari, often through a gene change called JAK2 V617F, and sometimes before blood counts look abnormal. Other contributors include inherited clotting tendencies such as factor V Leiden, antiphospholipid syndrome (an immune condition that promotes clots) and paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells and triggers clots. Estrogen-containing birth control pills and pregnancy raise clotting risk and can add to an existing tendency. More than one factor is often present, and in some people no cause is found despite thorough testing. Less often, the veins are compressed or invaded rather than clotted, for example by a liver tumor or a large cyst, or injured during liver surgery. This secondary form tends to occur in older people. In parts of Asia, a membrane across the vena cava is a more common cause, and lower income and poor nutrition have been linked to the condition.
Doctors consider Budd-Chiari when someone develops new fluid in the abdomen with upper abdominal pain, when liver disease has no clear explanation, or when a person with a known clotting or bone marrow disorder develops liver problems. Blood tests show whether the liver is injured and how well it is working, but they cannot show the blockage itself. Imaging makes the diagnosis. A Doppler ultrasound, which shows the direction and speed of blood flow, is usually the first test and can reveal a clot or a narrowed hepatic vein. A contrast CT scan or MRI maps the veins in more detail, shows the detour veins, and helps plan treatment. Some imaging patterns can also appear when heart problems back blood up into the liver, so those causes need to be ruled out. A liver biopsy is not needed to diagnose Budd-Chiari but may help when imaging is unclear, to judge scarring, or to check a suspicious nodule. Once the diagnosis is confirmed, testing turns to the cause: blood tests for the JAK2 gene change and other bone marrow disorders, for PNH, and for inherited or acquired clotting disorders. Some clotting tests are unreliable during an active clot, liver injury or blood thinner treatment, so results may need repeating or interpretation by a blood specialist (hematologist).
Treatment has three aims: stop the clot from growing, restore blood flow out of the liver, and treat whatever made the blood clot. Care usually involves a team of liver specialists (hepatologists), hematologists and interventional radiologists, who treat blood vessels through a thin tube (catheter) passed in through a vein. Most centers move step by step from the least invasive option to more invasive ones, depending on how a person responds. Blood thinners (anticoagulants) are the foundation and are recommended for nearly everyone, even without symptoms, unless there is a strong reason not to use them. They stop the clot from spreading and lower the chance of new clots, and in studies they are linked to better survival. Treatment often starts with injections of low-molecular-weight heparin and moves to a daily pill. The standard pill is warfarin, an older blood thinner whose dose is adjusted using regular INR blood tests (international normalized ratio, a measure of how long blood takes to clot). Newer direct oral anticoagulants are increasingly used, but evidence for them in Budd-Chiari comes only from small studies, and they need more caution when liver disease is advanced. The main trade-off of any blood thinner is bleeding, particularly from swollen veins in the esophagus (varices) or during procedures, which is why varices are often treated first and blood thinners may be paused around procedures. Because clots come back often, most people stay on a blood thinner for life. If the liver does not improve, the next step targets the blockage. When a short segment of a hepatic vein or the vena cava is narrowed, angioplasty widens it with a balloon, often followed by a stent to hold it open. When the veins cannot be reopened, a TIPS (transjugular intrahepatic portosystemic shunt) creates a new channel through the liver, lined with a covered stent, so blood can bypass the blockage and pressure falls. Stents and shunts can narrow or block again, which may mean a repeat procedure. Liver transplantation is considered when these steps fail, when the liver fails suddenly, or when advanced cirrhosis or liver cancer develops. Results are comparable with transplants done for other reasons, with about three in four recipients alive five years later in recent data, and a blood thinner usually continues afterward. The underlying cause is treated alongside all of this; a bone marrow disorder, for example, may need its own treatment from a hematologist. Birth control pills should be avoided, especially those containing estrogen, including after a transplant, so any hormonal contraception is worth discussing with the care team.
The course of Budd-Chiari syndrome varies widely. It depends on how quickly the veins became blocked, how many are involved, how much scarring is already present and what caused the clot. Outlook has improved with earlier diagnosis and stepwise treatment. In one recent European study of people treated with blood thinners, about 9 in 10 were alive without a transplant five years later. A sudden onset with liver failure carries the highest risk, while the slower form often does better. Daily life usually means long-term blood thinner treatment and its routines: regular INR checks for people taking warfarin, planning ahead for procedures, and paying attention to bleeding. Follow-up with a liver team continues for years. People with the chronic form have a higher chance of developing liver cancer (hepatocellular carcinoma), so guidelines recommend regular surveillance with imaging, often alongside a blood test for alpha-fetoprotein, a protein that can rise when liver cancer develops. Checks for varices and ongoing care for any bone marrow disorder are also common. Budd-Chiari does not rule out pregnancy, and outcomes for the mother are generally favorable, but miscarriage and other pregnancy complications are much more common than usual. Warfarin can harm a developing baby, so anyone taking it who could become pregnant should plan pregnancy in advance with the liver and blood specialists and contact them promptly if pregnancy happens. The usual switch is to low-molecular-weight heparin injections, which are considered safe in pregnancy, and varices may need checking first.
See a doctor promptly, within a day or two, about unexplained swelling of the abdomen with pain or fullness under the right ribs, especially if you have a known clotting or bone marrow disorder or take estrogen. If you already have Budd-Chiari, contact your liver team promptly if your abdomen swells quickly, your skin or eyes turn yellow, or you bruise or bleed easily while on a blood thinner. Get emergency care for vomiting blood, black or tarry stools, or new confusion or unusual drowsiness, since these can signal bleeding varices or liver failure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Budd-Chiari Syndrome is like, what's helped you, or ask the community a question.